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background
 
Although the initial results of endovascular repair of abdominal aortic aneurysms were
promising, current evidence from controlled studies does not convincingly show a re-
duction in 30-day mortality relative to that achieved with open repair.
 
methods
 
We conducted a multicenter, randomized trial comparing open repair with endovascu-
lar repair in 345 patients who had received a diagnosis of abdominal aortic aneurysm
of at least 5 cm in diameter and who were considered suitable candidates for both tech-
niques. The outcome events analyzed were operative (30-day) mortality and two com-
posite end points of operative mortality and severe complications and operative mor-
tality and moderate or severe complications.
 
results
 
The operative mortality rate was 4.6 percent in the open-repair group (8 of 174 pa-
tients; 95 percent confidence interval, 2.0 to 8.9 percent) and 1.2 percent in the endo-
vascular-repair group (2 of 171 patients; 95 percent confidence interval, 0.1 to 4.2 per-
cent), resulting in a risk ratio of 3.9 (95 percent confidence interval, 0.9 to 32.9). The
combined rate of operative mortality and severe complications was 9.8 percent in the
open-repair group (17 of 174 patients; 95 percent confidence interval, 5.8 to 15.2 per-
cent) and 4.7 percent in the endovascular-repair group (8 of 171 patients; 95 percent
confidence interval, 2.0 to 9.0 percent), resulting in a risk ratio of 2.1 (95 percent con-
fidence interval, 0.9 to 5.4).
 
conclusions
 
On the basis of the overall results of this trial, endovascular repair is preferable to open
repair in patients who have an abdominal aortic aneurysm that is at least 5 cm in diam-
eter. Long-term follow-up is needed to determine whether this advantage is sustained.
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lective surgical repair is indicat-
 
ed in patients with a large abdominal aor-
tic aneurysm. The threshold for surgery
is still a subject of debate but varies between 5.0
and 5.5 cm in diameter.
 
1-4
 
 Endovascular repair, pio-
neered by Parodi and Volodos in the early 1990s, is
a less invasive alternative to conventional open re-
pair.
 
5,6 
 
Endovascular repair usually involves two
small incisions made in the groin to expose the fem-
oral arteries. With the use of guidewires, catheters,
and specially designed introducer systems, a so-
called endograft is assembled inside the abdomi-
nal aortic aneurysm under fluoroscopic guidance,
thus excluding the aneurysm sac without opening
the abdomen.
From its inception, endovascular repair has been
used in patients for whom open repair poses a high
risk. At the same time, patients with relatively few
coexisting conditions are more likely to meet the
anatomical criteria for endovascular repair, includ-
ing the presence of a suitable infrarenal aortic neck
and absence of severe aortoiliac tortuosity and cal-
cification in the arterial wall.
 
7
 
 These factors lead to
selection in retrospective analyses and uncontrolled
prospective evaluations and make an unbiased as-
sessment of the benefits and risks of the two tech-
niques problematic.
 
8-15
 
Although the initial results of endovascular re-
pair were promising and the less invasive nature of
the procedure is appealing to many patients and
physicians, evidence is needed that demonstrates
the superiority of this approach over open repair,
as are conclusive data on cost-effectiveness.
 
16-18
 
We conducted a multicenter, randomized trial —
the Dutch Randomized Endovascular Aneurysm
Management (DREAM) trial — to compare opera-
tive mortality and complications and other out-
come events after elective open repair and endovas-
cular repair.
 
study design and patients
 
The design and methods of the trial have been de-
scribed in detail elsewhere.
 
19
 
 In brief, patients re-
ferred to surgery clinics at 24 centers in the Nether-
lands and 4 centers in Belgium who had received
a diagnosis of an abdominal aortic aneurysm of at
least 5 cm in diameter and who were considered
suitable candidates for both techniques were ran-
domly assigned to undergo open or endovascular
repair, after giving written informed consent. A pa-
tient’s suitability for endovascular repair was pri-
marily determined by means of endograft-depen-
dent anatomical criteria. A patient’s suitability for
open repair was determined by an internist or car-
diologist. Patients who needed to undergo emergen-
cy aneurysm repair were excluded from the study,
as were patients with inflammatory aneurysms,
anatomical variations, connective-tissue disease,
a history of organ transplantations, or a life expect-
ancy of less than two years. The study was per-
formed according to the principles of the Declara-
tion of Helsinki, and the institutional review board
of each participating hospital approved the proto-
col. Randomization was carried out centrally by
means of a computer-generated permuted-block
sequence and stratified according to study center
in blocks of four patients.
An independent data-monitoring and ethics
committee decided whether to continue the trial on
the basis of a single interim analysis of the 30-day
end points performed after half the required num-
ber of patients had been enrolled. In addition, se-
quential monitoring was used to monitor the inci-
dence of death from all causes and all moderate
and severe complications (not just those at 30 days)
in order to safeguard against divergent outcomes
beyond the perioperative period — for instance, as
a result of endograft failure.
 
20
 
surgical techniques
 
All repairs were carried out by surgical teams that
had performed at least five endovascular proce-
dures. Surgical teams that had performed less than
20 procedures were required to have an experienced
proctor assist them during the procedure. Only en-
dovascular devices that had been approved by the
U.S. Food and Drug Administration (FDA) or that
had an Investigational Device Exemption or Con-
formité Européen mark were allowed in the study.
Endovascular repair typically involves small inci-
sions in the groin to expose both femoral arteries,
although some surgeons prefer a total percutane-
ous approach. The endograft is composed of fabric
and metal stents and comes loaded in a specially
designed delivery system. Under fluoroscopic guid-
ance, this introducer system is fed through the iliac
arteries by means of catheters and guidewires until
the endograft is positioned correctly at the top and
bottom of the aneurysmal segment of the aorta.
Removal of the introducer system allows barbs or
other fixing devices to attach to the aortic wall and
hold the graft firmly in place, excluding blood flow
e
methods
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from the aneurysm sac and removing pressure from
the aneurysmal wall. The exposure and aneurysm-
repair technique used for open repair was at the sur-
geon’s discretion. 
 
end points
 
Complications were classified and graded accord-
ing to the reporting standards of the Ad Hoc Com-
mittee for Standardized Reporting Practices in
Vascular Surgery of the Society for Vascular Sur-
gery/International Society for Cardiovascular Sur-
gery.
 
21,22
 
 Three classes of complications (systemic,
local–nonvascular, and local–vascular or implant-
related) and three grades of severity (mild, moder-
ate, and severe) were used. Mild complications
were not considered in this analysis.
An outcome adjudication committee, consisting
of five vascular surgeons, assessed the class and
severity of each complication in a blinded fashion
and independently from each other. Disagreements
were resolved in a plenary consensus meeting. The
primary end point was a composite of operative
mortality and moderate or severe complications.
Operative complications were defined as those that
occurred within 30 days after surgery or more than
30 days after surgery but during the same admis-
sion (in-hospital mortality and complications). Oth-
er outcome events analyzed were operative mortal-
ity and the combination of operative mortality and
severe complications.
 
statistical analysis
 
The trial was designed to have 80 percent power to
show a reduction of 50 percent in the primary end
point at the two-sided 5 percent level with endovas-
cular repair, as compared with open repair. The in-
cidence of the primary end point in the open-repair
group was expected to be 20 percent. Four hundred
patients were required.
All analyses were based on all randomized pa-
tients who underwent aneurysm repair. Patients
were classified according to the original random-
ized allocation in all analyses. The risk of a compli-
cation after open repair was compared with that
after endovascular repair, and the results are pre-
sented as risk ratios and exact 95 percent confi-
dence intervals, derived with the use of StatXact
software (version 6.1, Cytel Software). Means (±SD)
together with medians and interquartile ranges
were used to describe continuous variables. Fre-
quencies and exact 95 percent confidence intervals
were calculated for categorical variables. Differenc-
es between treatment groups were evaluated with
the use of the Mann–Whitney U test for continuous
variables or Fisher’s exact test for proportions. All
reported P values are two-sided and are not adjust-
ed for multiple testing.
The study protocol specified that recruitment
would end by September 2003, with the enrollment
of 400 patients, and that the study would be com-
pleted in January 2004. After negotiations with the
sponsor of the study (the Health Insurance Council
of the Netherlands) about a possible extension,
three extra months were allowed, resulting in an
eventual enrollment that was 12 percent lower than
expected.
The corresponding author had full responsibil-
ity for the conduct of the trial, had full access to all
the data, and controlled the decision to publish.
The sponsor of the study had no role in the study
design.
 
characteristics of the patients
and treatment assignments
 
Between November 2000 and December 2003, 351
patients were randomly assigned to undergo either
open repair or endovascular repair (Fig. 1). Six pa-
tients did not undergo aneurysm repair after ran-
domization: four declined treatment (three assigned
to open repair and one to endovascular repair), one
died from a ruptured abdominal aortic aneurysm
before undergoing open repair, and one died from
pneumonia before undergoing endovascular repair.
The remaining 345 patients composed the treat-
ment groups: 174 patients in the open-repair group
and 171 in the endovascular-repair group.
The baseline characteristics of the patients and
aneurysms are shown in Table 1.
 
23 
 
Demographic
characteristics, coexisting conditions, cardiovas-
cular risk profiles, the distribution of American So-
ciety of Anesthesiologists classifications, and the
characteristics of the aneurysm were similar in the
two groups.
There were six crossovers: five patients who
were randomly assigned to undergo open repair
underwent endovascular repair, and one patient
assigned to endovascular repair underwent open
repair. Overall, in 96.6 percent of patients (339 of
351), the operation was started according to the
randomized assignment. The median interval be-
tween randomization and surgery was 39 days in
both the open-repair group (range, 4 to 260) and
results
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the endovascular-repair group (range, 1 to 183;
P=0.76).
 
surgical and postoperative data
 
Characteristics of the aneurysm-repair procedures
are shown in Table 2. In three patients who were
randomly assigned to undergo endovascular re-
pair, the procedure was converted intraoperatively
to an open procedure owing to access problems in
two and failed deployment in one. In one patient,
who was randomly assigned to open repair and who
had crossed over to endovascular repair, the proce-
dure was aborted owing to access problems. The
aneurysm was left untreated (Fig. 1).
General anesthesia was used in 98.3 percent of
patients in the open-repair group (in all except three
of the five patients who crossed over to endovas-
cular repair) and in 54.9 percent of patients in the
endovascular-repair group (P<0.001). An aorto-
aortic (tube) graft was used in 59.8 percent of
open repairs and in 1.8 percent of endovascular
repairs (P<0.001). At least one internal iliac artery
was sacrificed (intentionally or unintentionally)
in 4.0 percent of patients in the open-repair group,
 
Figure 1. Randomization, Treatment, and Analysis of Outcomes.
351 Patients randomized
178 Assigned to open repair 173 Assigned to endovascular repair
174 Included in analysis as randomized 171 Included in analysis as randomized
Open repair started in 170 Endovascular repair started in 175
Open repair completed in 173 Endovascular repair completed in 171
4 Did not undergo
aneurysm repair
3 Declined
1 Died
5 Underwent 
endovascular
repair
1 Underwent
open repair
3 Conversions
to open repair
1 Procedure aborted
(crossover from
open repair)
2 Did not undergo
aneurysm repair
1 Declined
1 Died
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* Plus–minus values are means ±SD. FEV
 
1
 
 denotes forced expiratory volume in one second, and ASA American Society 
of Anesthesiologists. The body-mass index is the weight in kilograms divided by the square of the height in meters. 
Because of rounding, not all percentages total 100.
† The Society for Vascular Surgery/International Society for Cardiovascular Surgery (SVS/ISCVS) risk-factor score for each 
of eight domains ranges from 0 (no risk factors) to 3 (severe risk factors).
 
21 
 
Total scores can range from 0 to 24, 
with higher scores indicating more risk factors.
‡ The Eurostar classification of aneurysm morphology has been described in detail by Harris et al.
 
23
 
§ The following were unfavorable neck features: reverse tapering, a diameter of more than 28 mm, angulation of more than 
30 degrees, length of less than 15 mm, a mural thrombus of more than 2 mm, and irregular wall or bulge.
¶The following were unfavorable iliac features: angulation of more than 90 degrees, a diameter of more than 18 mm, 
 
and a diameter of less than 6 mm or more than 50 percent stenosis.
 
Table 1. Baseline Characteristics of the Patients.*
Characteristic
Open Repair
(N=174)
Endovascular Repair
(N=171) P Value
 
Age — yr 69.5±6.8 70.7±6.6 0.11
Male sex — no. (%) 157 (90.2) 159 (93.0) 0.44
Moderate or severe SVS/ISCVS risk-factor score — %†
Diabetes mellitus 9.8 9.9 0.97
Tobacco use 54.0 64.9 0.07
Hypertension 54.0 57.9 0.92
Hyperlipidemia 53.6 47.0 0.22
Carotid-artery disease 15.1 13.5 0.71
Cardiac disease 46.6 40.9 0.30
Renal disease 7.5 7.6 0.98
Pulmonary disease 17.8 27.5 0.04
Sum of SVS/ISCVS risk-factor scores† 4.4±2.5 4.4±2.5 0.70
FEV
 
1
 
 — liters/sec 2.6±0.7 2.5±0.7 0.24
Body-mass index 26.6±4.1 26.2±3.4 0.42
ASA class — no. (%)
I (healthy status) 44 (25.3) 37 (21.6) 0.45
II (mild systemic disease) 106 (60.9) 119 (69.6) 0.09
III (severe systemic disease) 24 (13.8) 14 (8.2) 0.12
Data missing 0 1 (0.6)
Previous abdominal surgery — no. (%) 56 (32) 43 (25.1) 0.15
Maximal diameter of aneurysm — mm 0.68
Mean 60.0±8.5 60.6±9.0
Median 58 58
Interquartile range 54–65 55–65
Eurostar aneurysm morphology class — no. (%)‡
A (confined to aorta, distal aortic neck available) 20 (11.5) 12 (7.0) 0.15
B (involves aortic bifurcation, normal iliac arteries) 101 (58.0) 114 (66.7) 0.12
C (involves both proximal common iliac arteries) 20 (11.5) 16 (9.4) 0.30
D (extends into one iliac bifurcation) 15 (8.6) 14 (8.2) 0.90
E (extends into both iliac bifurcations) 18 (10.3) 15 (8.8) 0.62
Cylindrical shape of infrarenal aortic neck — no. (%) 127 (73.0) 107 (62.6) 0.05
Unfavorable features of infrarenal aortic neck — no. (%)§ 74 (42.5) 92 (53.8) 0.05
Iliac calcification <25% of the iliac segment — no. (%) 125 (71.8) 118 (69.0) 0.40
Unfavorable features of iliac arteries — no. (%)¶ 51 (29.3) 53 (31.0) 0.81
The New England Journal of Medicine 
Downloaded from nejm.org at RADBOUD UNIVERSITEIT NIJMEGEN on July 9, 2012. For personal use only. No other uses without permission. 
 Copyright © 2004 Massachusetts Medical Society. All rights reserved. 
 n engl j med 
 
351;16
 
www.nejm.org october 
 
14
 
, 
 
2004
 
The
 
 new england journal 
 
of
 
 medicine
 
1612
 
as compared with 17.0 percent of patients in the
endovascular-repair group (P<0.001).
Table 3 shows the main surgical and postoper-
ative data. As compared with open repair, endo-
vascular repair resulted in a significantly shorter
duration of surgery (P<0.001), less blood loss (P<
0.001) and blood replacement (P<0.001), a lower
rate of use of postoperative mechanical ventila-
tion (P<0.001), less of a change in the hematocrit
(P<0.001), a shorter stay in the medium care unit
and intensive care unit (P<0.001), and a shorter
hospital stay (P<0.001).
 
end points and adverse events
 
The operative mortality rate was 4.6 percent in the
open-repair group (8 of 174 patients; 95 percent
confidence interval, 2.0 to 8.9 percent) and 1.2 per-
cent in the endovascular-repair group (2 of 171
patients; 95 percent confidence interval, 0.1 to 4.2
percent), resulting in a risk ratio of 3.9 (95 percent
confidence interval, 0.9 to 32.9; P=0.10) (Table 4).
The combined rate of operative mortality and se-
vere complications was 9.8 percent in the open-
repair group (17 of 174 patients; 95 percent confi-
dence interval, 5.8 to 15.2 percent) and 4.7 percent
in the endovascular-repair group (8 of 171 patients;
95 percent confidence interval, 2.0 to 9.0 percent),
resulting in a risk ratio of 2.1 (95 percent confi-
dence interval, 0.9 to 5.4; P=0.10). The combined
rate of operative mortality and moderate or severe
complications was 23.6 percent in the open-repair
group (41 of 174 patients; 95 percent confidence
interval, 17.5 to 30.6 percent) and 18.1 percent in
the endovascular-repair group (31 of 171 patients;
95 percent confidence interval, 12.7 to 24.7 per-
cent), resulting in a risk ratio of 1.3 (95 percent con-
fidence interval, 0.9 to 2.0; P=0.23).
Table 4 shows the rates of operative complica-
tions according to class and grade for the two
groups. As compared with endovascular repair,
open repair resulted in a higher rate of moderate
and severe systemic complications as well as a high-
er rate of severe complications. The majority of the
difference was due to a higher rate of pulmonary
complications in the open-repair group (10.9 per-
cent vs. 2.9 percent). Local–vascular and implant-
related complications tended to be more frequent
after endovascular repair than after open repair,
but the difference was significant only for moder-
ate or severe complications. There were no signifi-
cant differences between the groups in the rate of
local–nonvascular complications.
 
* Because of rounding, not all percentages total 100.
† Values reflect patients who crossed over from open to endovascular repair.
‡ One of these patients crossed over from endovascular to open repair, and one 
underwent an immediate conversion owing to difficulty accessing an endovas-
cular bifurcated graft.
§ One of these patients underwent an immediate conversion owing to difficulty 
accessing an endovascular monoiliac graft, and one did so owing to failed de-
ployment of an endovascular bifurcated graft.
¶Two patients (one in each group) were not at risk for change in status, since 
both had bilateral occlusion of the internal iliac arteries preoperatively.
¿ The following other endografts were used: AneuRx (Medtronic) in 12 patients, 
Quantum LP (Cordis) in 8, Ancure (Guidant–EVT) in 5, Lifepath (Baxter 
 
Healthcare) in 4, and Endologix (Bard/Impra) in 1.
 
Table 2. Characteristics of the Aneurysm-Repair Procedures.*
Characteristic
Open Repair
(N=174)
Endovascular
Repair (N=171)
 
no. of patients (%)
 
Type of anesthesia
General 120 (69.0) 89 (52.0)
General and regional 51 (29.3) 5 (2.9)
Regional 2 (1.1)† 68 (39.8)
Local 1 (0.6)† 9 (5.3)
Configuration at completion
Conventional tube graft 104 (59.8) 2 (1.2)‡
Conventional bifurcated graft 65 (37.4) 2 (1.2)§
Endovascular tube graft — 1 (0.6)
Endovascular monoiliac graft — 6 (3.5)
Endovascular bifurcated graft 4 (2.3)† 160 (94.0)
Procedure aborted 1 (0.6)† —
Distal anastomosis
Aortoaortic graft 104 (59.8) 3 (1.8)
Other 69 (39.7) 165 (96.5)
Aortobiiliac 58 (33.3) 159 (93.0)
Aortoiliac or aortofemoral 8 (4.6) 6 (3.5)
Aortobifemoral 3 (1.7) —
Procedure aborted or converted 1 (0.6)† 3 (1.8)
Postoperative status of internal iliac artery 
relative to preoperative
patency¶
Unchanged 167 (96.0) 142 (83.0)
One of two patent internal iliac arteries 
lost or sacrificed
6 (3.5) 25 (14.6)
One of one patent internal iliac artery 
lost or sacrificed
1 (0.6)
Both internal iliac arteries lost or sacri-
ficed
1 (0.6) 3 (1.8)
Type of endograft used 3 (1.8)
Zenith (Cook) 2 (1.1)† 57 (33.3)
Talent (World Medical/Medtronic) 3 (1.7)† 46 (26.9)
Excluder (W.L. Gore and Associates) 0 37 (21.6)
Other¿ 0 30 (17.5)
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When taken together, the findings of this random-
ized trial comparing open and endovascular aneu-
rysm repair suggest that in patients who qualify
for either procedure, endovascular repair is prefer-
able to open repair over the first 30 days after the
procedure. To clarify these findings, some issues
need to be addressed. The size of the study group
was chosen so that we could demonstrate at least
a 10 percent absolute difference in the primary out-
come. Owing to time restrictions imposed by the
sponsor, the ultimate size of the patient group was
12 percent lower than anticipated. In addition, al-
though our estimate of a 20 percent rate of the pri-
mary end point after open repair was accurate (23.6
percent had such an end point), the rate after endo-
vascular repair turned out to be higher than expect-
ed (18.1 percent, rather than 10 percent). 
When designing the trial, we anticipated that
the rate of moderate complications after open re-
pair would be considerable. To avoid overlooking
a significant difference in the outcome accounted
for by differences in the rate of moderate complica-
tions, we incorporated these into the combined pri-
mary end point. Many of the complications includ-
ed in the Society for Vascular Surgery/International
Society for Cardiovascular Surgery definition of
moderate complications are important for the post-
operative care of patients with abdominal aortic
aneurysm and for the assessment of cost-effective-
ness. However, after an analysis of all moderate
complications, the outcome adjudication commit-
tee concluded that these complications were un-
likely to have an appreciable effect on clinical deci-
sion making.
As compared with open repair, endovascular
repair resulted in significantly better perioperative
outcomes, such as a lower rate of systemic compli-
cations (mainly pulmonary), less blood loss, a brief-
er duration of surgery, a lower rate of use of postop-
erative mechanical ventilation, and shorter hospital
stays, all reflecting the less invasive nature of the en-
dovascular approach. These results are consistent
with those of previously reported series and sys-
tematic reviews.
 
8-15
 
 This advantage, in combina-
tion with a near-significant advantage of endovas-
cular repair over open repair in terms of operative
mortality and combined operative mortality and
severe complications, makes a compelling case
for endovascular repair. The risk ratio for opera-
tive mortality was 3.9 for open repair as compared
with endovascular repair, with a 95 percent confi-
dence interval of 0.9 to 32.9. 
We are aware of three other randomized trials
comparing open repair with endovascular repair:
the Endovascular Aneurysm Repair (EVAR-1) trial
in the United Kingdom, the Anévrisme de l’aorte
abdominale: Chirurgie versus Endoprothèse (ACE)
trial in France, and the Open versus Endovascular
Repair (OVER) trial in the United States. Whereas
the last two trials are ongoing, the results of the
EVAR-1 trial have been published recently and are
similar to our results.
 
24
 
 Our trial and the EVAR-1
trial are almost equivalent in terms of patient selec-
tion (patients with low surgical risk) and outcome
criteria. Combining the results of the two trials
yields the most accurate approximation of the risk
ratio for in-hospital death to date: an operative
mortality of 5.8 percent in the open-repair group
(40 of 690 patients; 95 percent confidence interval,
4.2 to 7.8) and of 1.9 percent in the endovascular-
repair group (13 of 702 patients; 95 percent confi-
dence interval, 1.0 to 3.2), resulting in a risk ratio
of 3.1 (95 percent confidence interval, 1.7 to 6.2).
Although our results for endovascular repair
compare well with those in the literature, there is
some variation in reported operative mortality rates
after open repair among our randomized trial and
the randomized EVAR-1 trial, historical and re-
cent population-based studies,
 
9,10,25
 
 and the FDA
phase 2, pivotal, concurrent, controlled endograft
trials.
 
12-15
 
 Before the endovascular era, population-
based series reported operative mortality rates of
approximately 8 percent,
 
25
 
 whereas recent nation-
wide or statewide series have reported rates of ap-
proximately 4 percent.
 
9,10
 
 This difference can be
explained by the acceptance of a larger proportion
of high-risk patients for open repair as the only
available option in the older series. Operative mor-
tality rates in the open-repair (control) groups in
the FDA phase 2 trials ranged from 0 to 2.7 percent,
but these were highly selected patients. The recent
population-based series with an operative mortal-
ity of approximately 4 percent can be considered a
valid representation of the true operative mortality
rate for open repair and compares well with the re-
sults of our randomized trial of patients with low
surgical risk. It is hard to predict whether the over-
all population-based mortality associated with an-
eurysm repair would decrease with the widespread
use of endovascular repair, since its use in a broad-
er range of patients might diminish some of the
benefits that we and others have identified.
 
9,26
discussion
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Patients in our trial had to be eligible for either
operation in order to undergo randomization. Con-
sequently, our findings may not be generalizable
to patients who are not suitable candidates for open
repair. These patients frequently have multiple man-
ifestations of advanced atherosclerotic disease and
are at increased operative risk. Neither can our data
be generalized to patients who are not suitable for
endovascular repair, since these patients are likely
to have more challenging anatomy.
 
7
 
 Moreover, a
patient’s eligibility for endovascular repair is de-
pendent on the state of device technology. The in-
troduction of fenestrated and branched endografts
is expected to increase the proportion of patients
with abdominal aortic aneurysm who can be treat-
ed by endovascular repair in the near future.
 
27
 
Age is a well-known predictor of mortality af-
ter repair of abdominal aortic aneurysm. Open and
endovascular repair may yield similar results in rel-
atively young patients at low surgical risk, whereas
the latter approach may be particularly advanta-
geous in older and high-risk patients.
 
28
 
 The size of
our trial is not sufficient to permit a meaningful
subgroup analysis of the effect of age or coexisting
conditions on the difference in outcome between
open repair and endovascular repair. Other larger
and longer-term trials are needed to explore this is-
sue further. The sponsor of the current trial has
 
Table 3. Surgical and Postoperative Data.*
Variable Open Repair (N=174) Endovascular Repair (N=171) P Value
 
Duration of surgery — min <0.001
Mean 151 135
Median 150 120
Interquartile range 120 to 170 105 to 150
Estimated blood loss — ml <0.001
Mean 1654 394
Median 1500 250
Interquartile range 900 to 2300 100 to 500
Autologous blood returned — ml
Mean 486±482 —†
Median 420 —
Interquartile range 0 to 726 —
Homologous blood transfused — units <0.001
Mean 0.44 0.09
Median 0 0
Interquartile range 0 to 0 0 to 0
Intraoperative blood transfusion — % (95% CI) 72 (64 to 78) 6 (3 to 11) <0.001
Homologous blood products used — % (95% CI)‡ 21 (15 to 28) 4 (2 to 9) <0.001
Intravenous contrast — ml
Mean —§ 167±63
Median — 150
Interquartile range — 120 to 200
Total fluoroscopy time — min
Mean —§ 25±18
Median — 21
Interquartile range — 14 to 28
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* Plus–minus values are means ±SD. CI denotes confidence interval.
† Autologous blood was returned in three patients whose surgery was converted from endovascular repair to open repair 
(412, 700, and 1000 ml).
‡ Homologous blood products consisted of packed cells, fresh-frozen plasma, cryoprecipitate, and platelets.
§ In five patients who crossed over from open to endovascular repair, the volume of intravenous contrast used was not 
available for one and was 120, 129, 200, and 200 ml in the other four, and the total fluoroscopy time was not available 
for one and was 13, 37, 39, and 40 minutes in the other four.
¶ The stay in the medium care unit (MCU) and the intensive care unit (ICU) included the time spent in the recovery room.
¿ For the change in hematocrit, expressed as a fraction (preoperative value minus postoperative [day 1] value), 140 (80.5 
percent) pairs were available for the open-repair group and 136 (79.5 percent) pairs were available for the endovascular-
repair group.
** For the change in creatinine level (preoperative value minus postoperative [day 2] value), 161 (92.5 percent) pairs were 
available for the open-repair group and 134 (78.4 percent) pairs were available for the endovascular-repair group. 
 
To convert values for creatinine to milligrams per deciliter, divide by 88.4.
 
Table 3. (Continued.)
Variable Open Repair (N=174) Endovascular Repair (N=171) P Value
 
Duration of MCU or ICU stay — hr¶ <0.001
Mean 72 16
Median 23 3
Interquartile range 21 to 47 0 to 20
Postoperative mechanical ventilation — % (95% CI) 51 (43 to 58) 6 (3 to 10) <0.001
Duration of postoperative mechanical ventilation — hr <0.001
Mean 34 5
Median 1 0
Interquartile range 0 to 6  0 to 0
Duration of hospitalization — days <0.001
Mean 13 6
Median 10 4
Interquartile range 8 to 15 3 to 6
Change in hematocrit¿ <0.001
Mean 0.09 0.07
Median 0.09 0.07
Interquartile range 0.05 to 0.12 0.04 to 0.10
≤20% Decrease in hematocrit — % (95% CI) 53 (44 to 61) 35 (27 to 43) 0.002
Change in creatinine — µmol/liter** 0.93
Mean ¡0.5 ¡5.4
Median 7 7
Interquartile range ¡6 to 17 ¡6.3 to 10
≥20% Increase in creatinine — % (95% CI) 13 (8 to 19) 13 (8 to 20) 1.00
 
funded an extension of the follow-up period for a
total of seven years after surgery; thus, our data ad-
dress only the perioperative issues.
The ultimate decision regarding which type of
repair should be used in a given patient with an ab-
dominal aortic aneurysm is based on a number of
factors, including the quality of life expected post-
operatively, cost-effectiveness, risk of sexual dys-
function, risk of aneurysm rupture, and reinter-
vention rate.
 
29
 
 These factors must be considered
before a final decision is reached. Our results in-
dicate that in patients who are candidates for both
techniques, endovascular repair is preferable to
open repair, given its lower rates of operative mor-
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* The standards of the Society for Vascular Surgery/International Society for Cardiovascular Surgery were used.
 
21
 
† For end points, only the most severe event in each patient was counted.
 
‡ For complications, all events that occurred in each patient were counted.
 
Table 4. End Points and Operative Complications.*
Variable
Open
Repair
(N=174)
Endovascular
Repair
(N=171)
Risk Ratio
(95% CI)
P 
Value
 
no. of patients (%)
 
End point†
 
Operative mortality 8 (4.6) 2 (1.2) 3.9 (0.9–32.9) 0.10
Operative mortality and severe 
complications
17 (9.8) 8 (4.7) 2.1 (0.9–5.4) 0.10
Operative mortality and moderate or 
severe complications
41 (23.6) 31 (18.1) 1.3 (0.9–2.0) 0.23
 
Systemic complications‡
 
Moderate and severe 46 (26.4) 20 (11.7) 2.3 (1.4–3.8) <0.001
Severe 19 (10.9) 6 (3.5) 3.1 (1.3–9.1) 0.01
Cardiac complications 10 (5.7) 9 (5.3)
Severe 2 (1.1) 3 (1.8)
Pulmonary complications 19 (10.9) 5 (2.9) 3.7 (1.5–11.9) 0.005
Severe 8 (4.6) 2 (1.2) 3.9 (0.9–32.9) 0.10
Renal complications 2 (1.1) 2 (1.2)
Severe 1 (0.6) 0 
Cerebrovascular or spinal cord 2 (1.1) 1 (0.6)
Severe 2 (1.1) 1 (0.6)
Bowel ischemia 2 (1.1) 1 (0.6)
Severe 2 (1.1) 0
Other 11 (6.3) 2 (1.2) 5.4 (1.4–53.5) 0.02
Severe 4 (2.3) 0
 
Local–vascular or implant-related 
complications‡
 
Moderate and severe 15 (8.6) 28 (16.4) 0.5 (0.3–0.9) 0.03
Severe 9 (5.2) 7 (4.1) 1.3 (0.5–4.0) 0.80
Hemorrhage 6 (3.4) 3 (1.8)
Severe 6 (3.4) 1 (0.6)
Graft complications 0 6 (3.5)
Severe 0 1 (0.6)
Graft infection 2 (1.1) 1 (0.6)
Severe 0 0 
Endovascular-leak intervention 0 2 (1.2)
Severe 0 1 (0.6)
Thromboembolic complications 2 (1.1) 2 (1.2)
Severe 1 (0.6) 0 
Obstruction of main renal artery 0 3 (1.8)
Severe 0 1 (0.6)
Arterial or graft obstruction 5 (2.9) 11 (6.4) 0.5 (0.1–1.2) 0.13
Severe 2 (1.1) 3 (1.8)
 
Local–nonvascular complications‡
 
Wound complications 6 (3.4) 6 (3.5)
Severe 2 (1.1) 1 (0.6)
Iatrogenic bowel perforation 1 (0.6) 0
Severe 1 (0.6) 0
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tality and complications and the significant reduc-
tion in the rates of systemic complications.
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